Evidence map›Paper›PMID 41854154›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2026

Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide.

Sonal Gupta, Manoj Kumar, Krishna Mohan Repaka, Amit Das, Ajit A Kengar, Drishty Satpati

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sonal GuptaRadiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.
Manoj KumarRadiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.
Krishna Mohan RepakaBoard of Radiation and Isotope Technology, Mumbai, India.
Amit DasProtein Crystallography Section, Bio-Science Group, Bhabha Atomic Research Centre, Mumbai, India.ORCID https://orcid.org/0000-0002-7968-3574
Ajit A KengarKET'S V. G. Vaze College, Mumbai University, Mumbai, India.
Drishty SatpatiRadiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.ORCID https://orcid.org/0000-0003-0676-6157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our pursuit of developing HER2-targeting radiolabeled peptides for detection and therapy of HER2-positive breast cancer, the previously reported rL-A9 peptide had shown promising potential. In the present work, a different variant of rL-A9 was designed by incorporation of peptide-based chelators for

Indexed as

Breast NeoplasmsChelating AgentsErb-b2 Receptor Tyrosine KinasesOrganotechnetium CompoundsPeptidesRadiopharmaceuticalsAmino Acid SequenceAnimalsCell Line, TumorFemaleHumansMiceMice, NudeTechnetiumTissue DistributionChelating AgentsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesOrganotechnetium CompoundsPeptidesRadiopharmaceuticalsTechnetiumHER2 receptorspeptide‐based chelatorsrL‐A9technetium‐99 m

Identifiers

PMID41854154
PMCPMC13001140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.